Cortigent, Inc (NASDAQ:CRGT) IPO will take place January, 15 on the NASDAQ exchange under the ticker CRGT.

The company is offering shares at an expected price between $9.00 and $11.00 per share with an insider lock-up period of 180 days ending on July 14, 2025.

See also: Benzinga IPO Calendar

About Cortigent, Inc

Cortigent, through its predecessor Second Sight Medical Products, Inc., is a pioneer in developing targeted neurostimulation systems to help patients recover critical body functions. Our technology combines advanced neuroscience with proprietary microelectronics, software, and data processing capabilities to provide artificial vision and potentially restore muscle movement.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.